Published in Health Business Week, November 18th, 2005
According to recent research from the People's Republic of China, "RNA interference (RNAi) has been successfully applied in suppression of hepatitis B virus (HBV) replication. To circumvent the problem that mutation in HBV genome may result in resistance when siRNA is further developed as an antiviral drug, in this study, we established a dual small interfering RNA (siRNA) expression system, which could simultaneously express two...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.